PE20140226A1 - Compuestos de triazolopiridina - Google Patents
Compuestos de triazolopiridinaInfo
- Publication number
- PE20140226A1 PE20140226A1 PE2013001371A PE2013001371A PE20140226A1 PE 20140226 A1 PE20140226 A1 PE 20140226A1 PE 2013001371 A PE2013001371 A PE 2013001371A PE 2013001371 A PE2013001371 A PE 2013001371A PE 20140226 A1 PE20140226 A1 PE 20140226A1
- Authority
- PE
- Peru
- Prior art keywords
- triazolo
- pyrazole
- pyridin
- phenyl
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
SE REFIERE A COMPUESTOS DERIVADOS DE TRIAZOLOPIRIDINA DE FORMULA (I) DONDE R1 ES HALOGENO, ALQUILO INFERIOR, HALOALQUILO INFERIOR, ENTRE OTROS; R2 ES H, HALOGENO, ALCOXI INFERIOR, ENTRE OTROS; R3 ES H, ALQUILO INFERIOR, HIDROXIALQUILO INFERIOR, ENTRE OTROS; R4 ES HIDROXILO, ALCOXI INFERIOR O NR5R6, EN DONDE R5 Y R6 SON CADA UNO H, ALQUILO INFERIOR, CICLOALQUILO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 1-METIL-5-(2-FENIL-[1,2,4]TRIAZOLO[1,5-a]PIRIDIN-7-ILCARBAMOIL)-1H-PIRAZOL-4-CARBOXILATO DE METILO; 4-(AZETIDINA-1-CARBONIL)-1-METIL-N-(2-FENIL-[1,2,4]TRIAZOLO[1,5-a]PIRIDIN-7-IL)-1H-PIRAZOL-5-CARBOXAMIDA; N4-(2-METOXIETIL)-N4,1-DIMETIL-N5-(2-FENIL-[1,2,4]TRIAZOLO[1,5-a]PIRIDIN-7-IL)-1H-PIRAZOL-4,5-DICARBOXAMIDA; ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE LA FOSFODIESTERASA 10A (PDE10A) SIENDO UTILES EN EL TRATAMIENTO DE ESQUIZOFRENIA, TRASTORNO PSICOTICO INDUCIDO POR DROGAS, TRASTORNO DE ANSIEDAD
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10194014 | 2010-12-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20140226A1 true PE20140226A1 (es) | 2014-03-08 |
Family
ID=45099086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2013001371A PE20140226A1 (es) | 2010-12-07 | 2011-12-05 | Compuestos de triazolopiridina |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US8349824B2 (es) |
| EP (1) | EP2649070B1 (es) |
| JP (1) | JP5932828B2 (es) |
| KR (1) | KR20130128426A (es) |
| CN (1) | CN103237803B (es) |
| AR (1) | AR084152A1 (es) |
| AU (1) | AU2011340685A1 (es) |
| BR (1) | BR112013013912A2 (es) |
| CA (1) | CA2816829C (es) |
| CL (1) | CL2013001591A1 (es) |
| CO (1) | CO6741154A2 (es) |
| CR (1) | CR20130239A (es) |
| CY (1) | CY1115863T1 (es) |
| DK (1) | DK2649070T3 (es) |
| EA (1) | EA022607B1 (es) |
| EC (1) | ECSP13012667A (es) |
| ES (1) | ES2520647T3 (es) |
| HR (1) | HRP20141200T1 (es) |
| IL (1) | IL225969A0 (es) |
| MA (1) | MA35086B1 (es) |
| MX (1) | MX2013006054A (es) |
| PE (1) | PE20140226A1 (es) |
| PL (1) | PL2649070T3 (es) |
| PT (1) | PT2649070E (es) |
| RS (1) | RS53677B1 (es) |
| SG (1) | SG190305A1 (es) |
| SI (1) | SI2649070T1 (es) |
| UA (1) | UA109037C2 (es) |
| WO (1) | WO2012076430A1 (es) |
| ZA (1) | ZA201303811B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013043518A1 (en) | 2011-09-22 | 2013-03-28 | Merck Sharp & Dohme Corp. | Imidazopyridyl compounds as aldosterone synthase inhibitors |
| US9193724B2 (en) | 2011-09-22 | 2015-11-24 | Merck Sharp & Dohme Corp. | Triazolopyridyl compounds as aldosterone synthase inhibitors |
| MX348447B (es) | 2012-02-09 | 2017-06-13 | Hoffmann La Roche | Proceso para la preparacion de derivados de 2-fenil-[1,2,4]triazol o[1,5-a]piridina. |
| EP2951176A1 (en) * | 2013-01-31 | 2015-12-09 | F. Hoffmann-La Roche AG | Radiolabeled compounds |
| CN105189493B (zh) * | 2013-02-27 | 2017-04-12 | 持田制药株式会社 | 新型吡唑衍生物 |
| CN105164126B (zh) * | 2013-04-30 | 2017-05-31 | 豪夫迈·罗氏有限公司 | 吡唑酰胺的Pd‑催化偶联 |
| BR112015029899B1 (pt) * | 2013-05-31 | 2020-07-21 | Nissan Chemical Corporation | composto de amida heterocíclica e sal do mesmo da formula (1), produto quimico agrícola e herbicida obtido |
| US10039764B2 (en) | 2013-07-12 | 2018-08-07 | University Of South Alabama | Treatment and diagnosis of cancer and precancerous conditions using PDE10A inhibitors and methods to measure PDE10A expression |
| WO2016017711A1 (ja) * | 2014-07-30 | 2016-02-04 | 持田製薬株式会社 | ピラゾール誘導体の製造方法 |
| US9902723B2 (en) | 2014-07-30 | 2018-02-27 | Mochida Pharmaceutical Co., Ltd. | Pyrazole derivative manufacturing method |
| WO2020021024A1 (en) * | 2018-07-26 | 2020-01-30 | Phenex Pharmaceuticals Ag | Substituted bicyclic compounds as modulators of the aryl hydrocarbon receptor (ahr) |
| KR20230040978A (ko) | 2020-06-05 | 2023-03-23 | 노에마 파르마 아게 | 투렛 증후군의 치료를 위한 포스포디에스테라제 10 억제제의 용도 |
| JP2024505515A (ja) * | 2021-01-28 | 2024-02-06 | ノエマ ファーマ アクツィエンゲゼルシャフト | 小児期発症流暢症の治療のための方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007508241A (ja) | 2003-07-31 | 2007-04-05 | バイエル・フアーマシユーチカルズ・コーポレーシヨン | Ｐｄｅ１０ａ阻害剤を用いる糖尿病および関連障害の処置方法 |
| TWI501965B (zh) | 2008-06-20 | 2015-10-01 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑之新穎苯基咪唑衍生物 |
-
2011
- 2011-12-01 US US13/308,588 patent/US8349824B2/en active Active
- 2011-12-05 UA UAA201308329A patent/UA109037C2/uk unknown
- 2011-12-05 ES ES11791543.9T patent/ES2520647T3/es active Active
- 2011-12-05 BR BR112013013912A patent/BR112013013912A2/pt not_active Application Discontinuation
- 2011-12-05 SI SI201130309T patent/SI2649070T1/sl unknown
- 2011-12-05 AR ARP110104533A patent/AR084152A1/es unknown
- 2011-12-05 EP EP11791543.9A patent/EP2649070B1/en active Active
- 2011-12-05 AU AU2011340685A patent/AU2011340685A1/en not_active Abandoned
- 2011-12-05 EA EA201390799A patent/EA022607B1/ru not_active IP Right Cessation
- 2011-12-05 KR KR1020137016458A patent/KR20130128426A/ko not_active Application Discontinuation
- 2011-12-05 PE PE2013001371A patent/PE20140226A1/es not_active Application Discontinuation
- 2011-12-05 SG SG2013037676A patent/SG190305A1/en unknown
- 2011-12-05 RS RS20140574A patent/RS53677B1/en unknown
- 2011-12-05 JP JP2013542480A patent/JP5932828B2/ja active Active
- 2011-12-05 MX MX2013006054A patent/MX2013006054A/es active IP Right Grant
- 2011-12-05 WO PCT/EP2011/071685 patent/WO2012076430A1/en active Application Filing
- 2011-12-05 CA CA2816829A patent/CA2816829C/en active Active
- 2011-12-05 PL PL11791543T patent/PL2649070T3/pl unknown
- 2011-12-05 PT PT117915439T patent/PT2649070E/pt unknown
- 2011-12-05 CN CN201180057674.XA patent/CN103237803B/zh active Active
- 2011-12-05 DK DK11791543.9T patent/DK2649070T3/da active
-
2013
- 2013-04-25 IL IL225969A patent/IL225969A0/en unknown
- 2013-04-25 CO CO13105814A patent/CO6741154A2/es active IP Right Grant
- 2013-05-22 CR CR20130239A patent/CR20130239A/es unknown
- 2013-05-24 ZA ZA2013/03811A patent/ZA201303811B/en unknown
- 2013-06-04 CL CL2013001591A patent/CL2013001591A1/es unknown
- 2013-06-06 EC ECSP13012667 patent/ECSP13012667A/es unknown
- 2013-06-20 MA MA36027A patent/MA35086B1/fr unknown
-
2014
- 2014-11-14 CY CY20141100951T patent/CY1115863T1/el unknown
- 2014-12-11 HR HRP20141200AT patent/HRP20141200T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20140226A1 (es) | Compuestos de triazolopiridina | |
| ATE457311T1 (de) | Als inhibitoren von proteinkinasen geeignete aminopyridine und aminopyrimidine | |
| PE20130306A1 (es) | Morfolinopirimidinas y su uso en terapia | |
| ATE526328T1 (de) | Als inhibitoren von proteinkinasen geeignete aminopyrimidine | |
| ATE474835T1 (de) | Als inhibitoren von proteinkinasen geeignete aminopyrimidine | |
| ME01269B (me) | Jedinjenja pirolo (2,3-d) pirimidina | |
| PE20150153A1 (es) | 7H-PIRROLO[2,3-d]PIRIMIDINAS 4-(AMINO-SUBSTITUIDAS) NOVEDOSAS COMO INHIBIDORES DE LRRK2 | |
| MX2009010728A (es) | Compuestos de imidazo[1,2-a]piridina como inhibidores de la tirosina-cinasa repectora. | |
| PE20141582A1 (es) | Pirimidinas anilladas sustituidas y uso de las mismas | |
| PE20090714A1 (es) | Imidazopiridazinas y pirrolo-pirimidinas sustituidas como inhibidores de cinasa de lipido | |
| EA200870409A1 (ru) | Антагонисты киназы pi3 | |
| PE20141557A1 (es) | Derivado de pirazoloquinolina | |
| MX2015014861A (es) | Pirimidinas sustituidas con heterocicloalquilo c-enlazado y sus usos. | |
| PE20110995A1 (es) | DERIVADOS DE PIRROLO[3,4-e]PIRIMIDINA COMO INHIBIDORES DE PDE1 | |
| ATE508126T1 (de) | Als kinaseinhibitoren geeignete aminopyrimidine | |
| ATE429427T1 (de) | Pyrimidinderivate als orexin-rezeptorantagonisten | |
| PE20141974A1 (es) | Compuestos de heterociclilo | |
| PE20091039A1 (es) | IMIDAZO PIRAZINAS FUSIONADAS ARILO Y HETEROARILO [1,5-a] COMO INHIBIDORES DE LA FOSFODIESTERASA 10 | |
| EA201101186A1 (ru) | Конденсированные пиримидины | |
| UA102251C2 (ru) | Производные аминодигидротиазина как ингибиторы васе для лечения болезни альцгеймера | |
| PE20121438A1 (es) | Derivados de imidazopiridina o imidazopirimidina como inhibidores de fosfodiesterasa 10a | |
| MY165113A (en) | Piperidinone carboxamide azaindane cgrp receptor antagonists | |
| ATE557014T1 (de) | Neue substituierte indolin-2-on-derivate und ihre verwendung als p38-mitogenaktivierte kinasehemmer | |
| PH12015501955B1 (en) | Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases | |
| IL192907A0 (en) | Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |